These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

507 related articles for article (PubMed ID: 30011792)

  • 1. Role of Damage Associated Molecular Pattern Molecules (DAMPs) in Aneurysmal Subarachnoid Hemorrhage (aSAH).
    Chaudhry SR; Hafez A; Rezai Jahromi B; Kinfe TM; Lamprecht A; Niemelä M; Muhammad S
    Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30011792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting High Mobility Group Box 1 in Subarachnoid Hemorrhage: A Systematic Review.
    Muhammad S; Chaudhry SR; Kahlert UD; Lehecka M; Korja M; Niemelä M; Hänggi D
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32295146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Janus Faced HMGB1 and Post-Aneurysmal Subarachnoid Hemorrhage (aSAH) Inflammation.
    Chaudhry SR; Shafique S; Sajjad S; Hänggi D; Muhammad S
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated Systemic IL-6 Levels in Patients with Aneurysmal Subarachnoid Hemorrhage Is an Unspecific Marker for Post-SAH Complications.
    Chaudhry SR; Stoffel-Wagner B; Kinfe TM; Güresir E; Vatter H; Dietrich D; Lamprecht A; Muhammad S
    Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29194369
    [No Abstract]   [Full Text] [Related]  

  • 5. Temporal profile of serum mitochondrial DNA (mtDNA) in patients with aneurysmal subarachnoid hemorrhage (aSAH).
    Chaudhry SR; Frede S; Seifert G; Kinfe TM; Niemelä M; Lamprecht A; Muhammad S
    Mitochondrion; 2019 Jul; 47():218-226. PubMed ID: 30529453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarker Discovery in Cerebral Vasospasm after Aneurysmal Subarachnoid Hemorrhage.
    Przybycien-Szymanska MM; Ashley WW
    J Stroke Cerebrovasc Dis; 2015 Jul; 24(7):1453-64. PubMed ID: 25957908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aneurysmal subarachnoid hemorrhage lead to systemic upregulation of IL-23/IL-17 inflammatory axis.
    Chaudhry SR; Güresir E; Vatter H; Kinfe TM; Dietrich D; Lamprecht A; Muhammad S
    Cytokine; 2017 Sep; 97():96-103. PubMed ID: 28609751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of High-Mobility Group Box 1 Polymorphism on Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage.
    Hendrix P; Foreman PM; Harrigan MR; Fisher WS; Vyas NA; Lipsky RH; Lin M; Walters BC; Tubbs RS; Shoja MM; Pittet JF; Mathru M; Griessenauer CJ
    World Neurosurg; 2017 May; 101():325-330. PubMed ID: 28189859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurocognitive outcomes after aneurysmal subarachnoid hemorrhage: Identifying inflammatory biomarkers.
    Watson E; Ding D; Khattar NK; Everhart DE; James RF
    J Neurol Sci; 2018 Nov; 394():84-93. PubMed ID: 30240942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levels of Interleukin-1β, Interleukin-18, and Tumor Necrosis Factor-α in Cerebrospinal Fluid of Aneurysmal Subarachnoid Hemorrhage Patients May Be Predictors of Early Brain Injury and Clinical Prognosis.
    Lv SY; Wu Q; Liu JP; Shao J; Wen LL; Xue J; Zhang XS; Zhang QR; Zhang X
    World Neurosurg; 2018 Mar; 111():e362-e373. PubMed ID: 29277532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of excellent functional outcome in aneurysmal subarachnoid hemorrhage.
    Pegoli M; Mandrekar J; Rabinstein AA; Lanzino G
    J Neurosurg; 2015 Feb; 122(2):414-8. PubMed ID: 25495745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated level of cerebrospinal fluid and systemic chemokine CCL5 is a predictive biomarker of clinical outcome after aneurysmal subarachnoid hemorrhage (aSAH).
    Chaudhry SR; Kinfe TM; Lamprecht A; Niemelä M; Dobreva G; Hänggi D; Muhammad S
    Cytokine; 2020 Sep; 133():155142. PubMed ID: 32485621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of traumatic subarachnoid hemorrhage on pathological properties in diffuse brain injury: a comparison with aneurysmal subarachnoid hemorrhage].
    Fukuda T; Mikoshiba M; Fukushima C; Nishi T; Nakajima S; Hasue M; Ikeda K; Sengoku Y; Ito H
    No Shinkei Geka; 1996 Aug; 24(8):723-31. PubMed ID: 8741407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated HMGB1 and sRAGE levels in cerebrospinal fluid of aneurysmal subarachnoid hemorrhage patients.
    Chu XH; Hu HY; Godje ISG; Zhu LJ; Zhu JB; Feng YL; Wang H; Zhang YB; Huang J; Sun XG
    J Stroke Cerebrovasc Dis; 2023 May; 32(5):107061. PubMed ID: 36871437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Constitutive DAMPs in CNS injury: From preclinical insights to clinical perspectives.
    Castellanos-Molina A; Bretheau F; Boisvert A; Bélanger D; Lacroix S
    Brain Behav Immun; 2024 Nov; 122():583-595. PubMed ID: 39222725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of inflammation (leukocyte-endothelial cell interactions) in vasospasm after subarachnoid hemorrhage.
    Chaichana KL; Pradilla G; Huang J; Tamargo RJ
    World Neurosurg; 2010 Jan; 73(1):22-41. PubMed ID: 20452866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotective Strategies in Aneurysmal Subarachnoid Hemorrhage (aSAH).
    Weiland J; Beez A; Westermaier T; Kunze E; Sirén AL; Lilla N
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34064048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review of aneurysmal subarachnoid hemorrhage--focus on treatment, anesthesia, cerebral vasospasm prophylaxis, and therapy.
    Lin BF; Kuo CY; Wu ZF
    Acta Anaesthesiol Taiwan; 2014 Jun; 52(2):77-84. PubMed ID: 25016512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compartmentalisation of the inflammatory response following aneurysmal subarachnoid haemorrhage.
    Al-Tamimi YZ; Bhargava D; Orsi NM; Teraifi A; Cummings M; Ekbote UV; Quinn AC; Homer-Vanniasinkam S; Ross S
    Cytokine; 2019 Nov; 123():154778. PubMed ID: 31323526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycyrrhizic acid confers neuroprotection after subarachnoid hemorrhage via inhibition of high mobility group box-1 protein: a hypothesis for novel therapy of subarachnoid hemorrhage.
    Sun Q; Wang F; Li W; Li W; Hu YC; Li S; Zhu JH; Zhou M; Hang CH
    Med Hypotheses; 2013 Oct; 81(4):681-5. PubMed ID: 23932051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.